Sign In

Christopher D. Jensen, PhD, MPH

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3665 (phone)
christopher.d.jensen@kp.org


Christopher D. Jensen, PhD, MPH, is a staff scientist at the Kaiser Permanente Northern California Division of Research. He received his doctoral training in Epidemiology at the University of California, Berkeley, School of Public Health. Before his position at the Division of Research, Dr. Jensen served as a Research Specialist and Lecturer at the University of California, Berkeley, School of Public Health, and before that worked in research and development in the private sector. Dr. Jensen is a cancer epidemiologist whose research interests primarily center around optimizing the process of screening for cancer, particularly colorectal cancer.

Current Position(s):

  • Staff Scientist, Division of Research, Kaiser Permanente Northern California

Section Affiliations:

Primary Research Interests:

  • Optimizing the colorectal cancer screening process
  • Use of fecal immunochemical testing and colonoscopy for colorectal cancer screening
  • Physician adenoma detection rate as a quality metric
  • Interventions aimed at improving cancer screening and outcomes

    No results found matching criteria

    Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study

    Author(s): Doubeni CA; Quinn VP; Weiss NS; Fletcher RH; et al.

    Gut. 2018 02;67(2):291-298. Epub 2016-10-12.

    PubMed abstract

    Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

    Author(s): Corley DA; Schottinger JE; Fireman BH; Levin TR; Levin TR; et al.

    JAMA. 2017 Apr 25;317(16):1631-1641.

    PubMed abstract

    Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study

    Author(s): Jensen CD; Quinn VP; Zhao WK; Levin TR; Mysliwiec PA; Mysliwiec PA; et al.

    Ann Intern Med. 2016 Apr 5;164(7):456-63. Epub 2016-01-26.

    PubMed abstract

    Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting

    Author(s): Jensen CD; Zauber AG; Ghai NR; Quesenberry CP; Corley DA; Corley DA; et al.

    Clin Gastroenterol Hepatol. 2015 Apr;13(4):739-46. Epub 2014-10-25.

    PubMed abstract

    Adenoma detection rate and risk of colorectal cancer and death

    Author(s): Corley DA; Doubeni CA; Schottinger JE; Quesenberry CP; Quesenberry CP; et al.

    N Engl J Med. 2014 Apr 3;370(14):1298-306.

    PubMed abstract

    Program components and results from an organized colorectal cancer screening program using annual fecal immunochemical testing

    Author(s): Selby, Kevin; Jensen, Christopher D; Levin, Theodore R; Lee, Jeffrey K; Schottinger, Joanne E; Zhao, Wei K; Corley, Douglas A; Doubeni, Chyke A

    Clin Gastroenterol Hepatol. 2022 01;20(1):145-152. Epub 2020-09-30.

    PubMed abstract

    The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer

    Author(s): Doubeni CA; Jensen CD; Ghai NR; Zhao WK; Weiss NS; et al.

    J Med Screen. 2021 06;28(2):140-147. Epub 2020-05-21.

    PubMed abstract

    Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-based Colorectal Cancer Screening Program

    Author(s): Levin TR; Jensen CD; Chawla NM; Sakoda LC; Lee JK; Zhao WK; Landau MA; Herm A; Eby E; Quesenberry CP; Corley DA

    Gastroenterology. 2020 11;159(5):1695-1704.e1. Epub 2020-07-20.

    PubMed abstract

    Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems

    Author(s): Ghai NR; Chubak J; Corley DA; et al.

    Cancer Prev Res (Phila). 2020 11;13(11):947-958. Epub 2020-07-15.

    PubMed abstract

    Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population

    Author(s): Lee JK; Merchant SA; Schneider JL; Jensen CD; Fireman BH; Quesenberry CP; Corley DA

    Am J Gastroenterol. 2020 05;115(5):706-715.

    PubMed abstract

    Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population

    Author(s): Lee JK; Doubeni CA; Quesenberry CP; Orav EJ; Corley DA; et al.

    Gastroenterology. 2020 03;158(4):884-894.e5. Epub 2019-10-04.

    PubMed abstract

    Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings

    Author(s): Lee JK; Zauber AG; Quesenberry CP; Doubeni CA; Corley DA; et al.

    JAMA Netw Open. 2019 09 04;2(9):e1911513. Epub 2019-09-04.

    PubMed abstract

    Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study

    Author(s): Selby K; Jensen CD; Zhao WK; Lee JK; Slam A; Schottinger JE; Bacchetti P; Levin TR; Corley DA

    Clin Transl Gastroenterol. 2019 02;10(2):e00010.

    PubMed abstract

    Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers

    Author(s): Tollivoro TA; Fireman B; Quesenberry CP; Corley DA; Corley DA; et al.

    Gastrointest Endosc. 2019 01;89(1):168-176.e3. Epub 2018-08-23.

    PubMed abstract

    Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening

    Author(s): Ghai NR; Jensen CD; Corley DA; Doubeni CA; Schottinger JE; Zauber AG; Lee AT; Contreras R; Levin TR; Lee JK; Quinn VP

    Clin Transl Gastroenterol. 2018 09 21;9(9):186. Epub 2018-09-21.

    PubMed abstract

    Modifiable Failures in the Colorectal Cancer Screening Process and Their Association with Risk of Death

    Author(s): Doubeni CA; Jensen CD; Corley DA; et al.

    Gastroenterology. 2019 01;156(1):63-74.e6. Epub 2018-09-27.

    PubMed abstract

    Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large, Community-based Population

    Author(s): Levin TR; Jensen CD; Zhao WK; Fireman BH; Doubeni CA; Doubeni CA; et al.

    Gastroenterology. 2018 11;155(5):1383-1391.e5. Epub 2018-07-19.

    PubMed abstract

    Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study

    Author(s): Selby K; Doubeni CA; Corley DA; Corley DA; et al.

    Ann Intern Med. 2018 10 02;169(7):439-447. Epub 2018-09-18.

    PubMed abstract

    Patterns and predictors or repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States

    Author(s): Singal AG; Kamineni A; Halm EA; et al.

    Am J Gastroenterol. 2018 05;113(5):746-754. Epub 2018-02-27.

    PubMed abstract

    Diagnosis of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting

    Author(s): Li D; Postlethwaite D; Levin TR; Levin TR; et al.

    Gastrointest Endosc. 2018 Mar;87(3):755-765.e1. Epub 2017-08-24.

    PubMed abstract

    Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study

    Author(s): Doubeni CA; Quinn VP; Weiss NS; Fletcher RH; et al.

    Gut. 2018 02;67(2):291-298. Epub 2016-10-12.

    PubMed abstract

    Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review

    Author(s): Selby K; Baumgartner C; Levin TR; Doubeni CA; Zauber AG; Schottinger J; Jensen CD; Lee JK; Corley DA

    Ann Intern Med. 2017 Oct 17;167(8):565-575. Epub 2017-10-10.

    PubMed abstract

    Primary care visit use after positive fecal immunochemical test for colorectal cancer screening

    Author(s): Hillyer GC; Jensen CD; Zhao WK; Neugut AI; Lebwohl B; Tiro JA; Kushi LH; Corley DA

    Cancer. 2017 Oct 01;123(19):3744-3753. Epub 2017-06-16.

    PubMed abstract

    Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program

    Author(s): Fedewa SA; Corley DA; Jensen CD; Zhao W; Goodman M; Jemal A; Ward KC; Levin TR; Doubeni CA

    Am J Prev Med. 2017 Sep;53(3):335-344. Epub 2017-04-17.

    PubMed abstract

    Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis

    Author(s): Corley DA; Schottinger JE; Fireman BH; Levin TR; Levin TR; et al.

    JAMA. 2017 Apr 25;317(16):1631-1641.

    PubMed abstract

    Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue

    Author(s): Levin TR; Jensen CD; Berger BM; et al.

    Dig Dis Sci. 2017 Mar;62(3):678-688. Epub 2017-01-02.

    PubMed abstract

    Endoscopist Fatigue Estimates and Colonoscopic Adenoma Detection in a Large Community-Based Setting

    Author(s): Lee A; Jensen CD; Marks AR; Zhao WK; Doubeni CA; Zauber AG; Quinn VP; Levin TR; Corley DA

    Gastrointest Endosc. 2017 Mar;85(3):601-610.e2. Epub 2016-10-01.

    PubMed abstract

    Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system

    Author(s): Chao C; Silverberg MJ; Becerra TA; Corley DA; Jensen CD; Chen Q; Quinn VP

    Am J Obstet Gynecol. 2017 Feb;216(2):151.e1-151.e9. Epub 2016-10-14.

    PubMed abstract

    Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System

    Author(s): Mehta SJ; Corley DA; Doubeni CA; Doubeni CA; et al.

    J Gen Intern Med. 2016 Nov;31(11):1323-1330. Epub 2016-07-13.

    PubMed abstract

    Consequences of Increasing Time to Colonoscopy Examination Following Positive Result From Fecal Colorectal Cancer Screening Test

    Author(s): Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I

    Clin Gastroenterol Hepatol. 2016 Oct;14(10):1445-1451.e8. Epub 2016-05-19.

    PubMed abstract

    Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study

    Author(s): Jensen CD; Quinn VP; Zhao WK; Levin TR; Mysliwiec PA; Mysliwiec PA; et al.

    Ann Intern Med. 2016 Apr 5;164(7):456-63. Epub 2016-01-26.

    PubMed abstract

    Factors Influencing Variation in Physician Adenoma Detection Rates: a Theory-Based Approach for Performance Improvement

    Author(s): Atkins L; Hunkeler EM; Jensen CD; Michie S; Lee JK; Doubeni CA; Zauber AG; Levin TR; Quinn VP; Corley DA

    Gastrointest Endosc. 2016 Mar;83(3):617-26.e2. Epub 2015-09-11.

    PubMed abstract

    METFORMIN USE AND RISK OF COLORECTAL ADENOMA AFTER POLYPECTOMY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Author(s): Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA

    Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1692-8. Epub 2015-09-16.

    PubMed abstract

    Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR

    Author(s): Goodman M; Fletcher RH; Doria-Rose VP; Jensen CD; Zebrowski AM; Becerra TA; Quinn VP; Zauber AG; Corley DA; Doubeni CA

    J Comp Eff Res. 2015 Nov;4(6):541-51. Epub 2015-07-23.

    PubMed abstract

    Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model

    Author(s): Meester RG; Doubeni CA; Lansdorp-Vogelaar I; Jensen CD; van der Meulen MP; Levin TR; Quinn VP; Schottinger JE; Zauber AG; Corley DA; van Ballegooijen M

    JAMA. 2015 Jun 16;313(23):2349-58.

    PubMed abstract

    Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting

    Author(s): Jensen CD; Zauber AG; Ghai NR; Quesenberry CP; Corley DA; Corley DA; et al.

    Clin Gastroenterol Hepatol. 2015 Apr;13(4):739-46. Epub 2014-10-25.

    PubMed abstract

    Development and validation of an algorithm for classifying colonoscopy indication

    Author(s): Lee JK; Jensen CD; Lee A; Doubeni CA; Zauber AG; Levin TR; Zhao WK; Corley DA

    Gastrointest Endosc. 2015 Mar;81(3):575-582.e4. Epub 2015-01-08.

    PubMed abstract

    Adenoma detection rate and risk of colorectal cancer and death

    Author(s): Corley DA; Doubeni CA; Schottinger JE; Quesenberry CP; Quesenberry CP; et al.

    N Engl J Med. 2014 Apr 3;370(14):1298-306.

    PubMed abstract

    Variation of Adenoma Prevalence by Age, Sex, Race, and Colon Location in a Large Population: Implications for Screening and Quality Programs

    Author(s): Corley DA; Jensen CD; Marks AR; Zhao WK; de Boer J; Levin TR; Doubeni C; Fireman BH; Quesenberry CP

    Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80. Epub 2012 Sep 14.

    PubMed abstract

    Can we improve adenoma detection rates? A systematic review of intervention studies

    Author(s): Corley DA; Jensen CD; Marks AR

    Gastrointest Endosc. 2011 Sep;74(3):656-65. Epub 2011 Jul 13.

    PubMed abstract